N@N

Robert Burns Reiterated (BNTX) at Strong Buy and Held Target at $113 on, May 28th, 2024

Robert Burns of HC Wainwright & Co., Reiterated "BioNTech SE" (BNTX) at Strong Buy and Held Target at $113 on, May 28th, 2024.

Robert has made no other calls on BNTX in the last 4 months.

There are 7 other peers that have a rating on BNTX. Out of the 7 peers that are also analyzing BNTX, 4 agree with Robert's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Cory Kasimov of "Evercore ISI Group" Initiated at Hold and Held Target at $100 on, Tuesday, May 14th, 2024
• Yaron Werber of "TD Cowen" Maintained at Hold with Increased Target to $98 on, Tuesday, May 7th, 2024
• Eliana Merle of "UBS" Maintained at Hold with Decreased Target to $101 on, Wednesday, March 27th, 2024
• Chris Shibutani of "Goldman Sachs" Maintained at Hold with Decreased Target to $100 on, Wednesday, February 28th, 2024

These are the ratings of the 3 analyists that currently disagree with Robert

---

• Etzer Darout of "BMO Capital" Maintained at Buy with Decreased Target to $122 on, Tuesday, May 7th, 2024
• Jessica Fye of "JP Morgan" Maintained at Sell with Decreased Target to $90 on, Friday, March 22nd, 2024
• Bill Maughan of "Canaccord Genuity" Reiterated at Strong Buy and Held Target at $171 on, Thursday, March 21st, 2024

Contributing Sources

---